Buy Sandra pills 0.25 g, 30 pcs
  • Buy Sandra pills 0.25 g, 30 pcs

Sandra

Pharmacentre VILAR ZAO
1385 Items
2019-09-19
Dosage form
Brand & Manufacturer
Package Size
$23.44
Quantity
  • done All payments are SSL encrypted
  • done Full Refund if you haven't received your order
  • done International shipping to the USA, UK and Europe

Clinical Pharmacology

Sandra has anti-inflammatory, antipyretic, fortifying effect.

Indications

For prophylaxis and as part of complex therapy as a symptomatic remedy for “colds” diseases (ARVI) and influenza states (fever, general weakness, headache) in order to increase the nonspecific resistance of the organism.

Composition

1 homeopathic sublingual tablet contains:
active substances: Asonitum soongaricum (Aconitum Sungaricum) D1 2.3 mg, Verbascum densiflorum (Verbascum Densiflorum) D1 2.3 mg, Alchemilla vulgaris (Alchemilla vulgaris) D1 2.3 mg, Echinacea purpurea (Echinacea purpuraa) D1) D1 2.3 mg, Echinacea purpurea (Echinacea purpurea) (),) piperita (ment piperit) D1 2.3 mg, Daphne mezereum (Mezereum) (dafne mezherema (mezherem) D1 2.3 mg, Apis mellifica (Apis) (apis mellifica (apis) D1 2.3 mg, Atropa belladonna (Belladonna) (atropa belladonna (belladonna) D1 2.3 mg, Bryonia dioica (brionium dioica) D1 2.3 mg, Hydrargyri dichloridum (hydrargiri dichloridum) 0.00025 mg, excipients: sugar (refined sugar) - 225.55 mg; gelatin - 1.25 mg; calcium stearinate (calcium stearate) - 2.5 mg, mA pill pills - 250 mg.

No customer reviews for the moment.

Write your review

Write your review

Sandra

Dosage and Administration

One tablet of Sandra is placed under the tongue and held in the mouth until completely dissolved. For treatment in the first 2-3 days, apply 1 tablet every 2 hours (7-8 times per day). After reducing the temperature in the next 2-3 days, use 1 tablet 4 times a day. The course of treatment is 5-6 days.

For prophylaxis during an outbreak of ARVI, the drug is taken 1 tablet 4 times a day.

Adverse reactions

Allergic reactions are possible.

Contraindications

Hypersensitivity to the drug components Sandra, age up to 18 years.

Pregnancy and Lactation

Use during pregnancy and during breastfeeding is possible if the expected benefit to the mother outweighs the potential risk to the fetus and child. Need to consult a doctor.

Special instructions

The drug does not affect the ability to drive vehicles and engage in other potentially hazardous activities that require high concentration of attention and psychomotor speed reactions.

Information for patients with diabetes mellitus: one tablet of the drug contains 225.55 mg of sucrose (refined sugar), which corresponds to 0.019 XE (bread units). Before using the drug should consult a doctor.

  • Brand name: Sandra
  • Active ingredient: Homeopathic composition
  • Dosage form: Homeopathic sublingual pills.
  • Manufacturer: Pharmacentre VILAR ZAO
  • Country of Origin: Russia

Studies and clinical trials of Sandra (Click to expand)

  1. Prenatal diagnosis and carrier screening for fragile X by PCR
  2. Alice Vance (?Das B�renweib?): A historical case of Nievergelt syndrome
  3. Description of a new mutation and characterization of FGFR1, FGFR2, and FGFR3 mutations among Brazilian patients with syndromic craniosynostoses
  4. Mosaic trisomy 16 ascertained through amniocentesis: Evaluation of 11 new cases
  5. Lethal multiple pterygium syndrome in four male fetuses in a family: Evidence for an X-linked recessive subtype?
  6. Confirmation of linkage of hereditary partial lipodystrophy to chromosome 1q21-22
  7. Genetic epidemiological study of maternal and paternal transmission of alzheimer's disease
  8. Linkage of type II and type III cystinuria to 19q13.1: Codominant inheritance of two cystinuric alleles at 19q13.1 produces an extreme stone-forming phenotype
  9. Unique frequency of known mutations in Brazilian MPS I patients
  10. Exclusion of the branchio-oto-renal syndrome locus (EYA1) from patients with branchio-oculo-facial syndrome
  11. Investigation of germline PTEN, p53, p16INK4A/p14ARF, and CDK4 alterations in familial glioma
  12. Twenty-five thousand-year-old triple burial from Dolní Věstonice: An ice-age family?
  13. Sex differences in mortality of Japanese macaques: Twenty-one years of data from the Arashiyama West population
  14. Relationship of enamel hypoplasia to the pattern of tooth crown growth: A discussion
  15. Dental defects of congenital syphilis
  16. A structural difference between the cell surfaces of humans and the great apes
  17. K:CI cotransport in red cells of transgenic mice expressing high levels of human hemoglobin S
  18. Viral Burden and Disease Progression in HIV-1–Infected Patients with Sickle Cell Anemia
  19. Unintegrated HIV-1 circular 2-LTR proviral DNA as a marker of recently infected cells: Relative effect of recombinant CD4, zidovudine, and saquinavir in vitro
  20. Determinants of software maintenance profiles: an empirical investigation
  21. Characterization of C4-2 as a tumor-suppressor gene in human brain tumors
  22. Cloning, sequence, and developmental expression analysis of C4-2, a potential brain tumor-suppressor gene
  23. Application of the differential hybridization of Atlas™ human expression arrays technique in the identification of differentially expressed genes in human glioblastoma multiforme tumor tissue
  24. Laser welding for vascular anastomosis using albumin solder: An approach for MID-CAB

8 other products in the same category:

arrow_upward